We found that PRDM3 was strongly expressed in precancerous PanIN lesions (Fig. 1c–c’) and well-differentiated PDAC from patients (Fig. 1d–d’), while moderately to poorly differentiated cancer cells showed little to no staining of PRDM3 (Fig. 1e–e’, f–f’, Table 1). Here, MECOM is linked to cancer.